www.cidara.com Open in urlscan Pro
141.193.213.10  Public Scan

Form analysis
1 forms found in the DOM

GET https://www.cidara.com/

<form role="search" action="https://www.cidara.com/" method="GET">
  <input type="text" name="s" id="s" value="" aria-label="Search" placeholder="Search">
  <span>Hit enter to search or ESC to close</span>
</form>

Text Content

Skip to main content
 * Partnerships
 * Publications
 * Newsroom
 * Careers
 * Contact

Hit enter to search or ESC to close
Close Search
Menu
 * About
   * Overview
   * Leadership
   * Board of Directors
   * Scientific Advisory Board
 * Pipeline
 * Rezafungin
   * Overview
   * Treatment
   * Prevention
   * Expanded Access Policy
 * Cloudbreak®
   * Overview
   * Influenza
   * SARS-CoV-2 and Other Viruses
   * Oncology
 * Investors
   * Investor Overview
   * Press Releases
   * Events + Presentations
   * Company Information
   * Stock Information
   * Analyst Coverage
   * SEC Filings
   * Corporate Governance
   * News Alerts


 * 
 * 
 * 
 * 
 * 


CIDARA IS DEVELOPING LONG-ACTING THERAPEUTICS DESIGNED TO SAVE LIVES AND IMPROVE
THE STANDARD OF CARE FOR PATIENTS FACING SERIOUS DISEASES.

ANTIFUNGAL:
REZAFUNGIN

A next-generation once-weekly echinocandin being developed for both the
treatment and prevention of serious fungal infections

CLOUDBREAK®
DRUG-FC CONJUGATES

Highly potent, long-acting, drug-Fc conjugates (DFCs) designed to inhibit
specific disease targets while simultaneously engaging the immune system


CIDARA IS DEVELOPING LONG-ACTING THERAPEUTICS DESIGNED TO SAVE LIVES AND IMPROVE
THE STANDARD OF CARE FOR PATIENTS FACING SERIOUS DISEASES.

ANTIFUNGAL:
REZAFUNGIN

A next-generation once-weekly echinocandin being developed for both the
treatment and prevention of serious fungal infections

CLOUDBREAK®
DRUG-FC CONJUGATES

Highly potent, long-acting, drug-Fc conjugates (DFCs) designed to inhibit
specific disease targets while simultaneously engaging the immune system

PIPELINE

RECENT NEWS

CONTACT US

Cidara Therapeutics, Inc.
6310 Nancy Ridge Drive, Suite 101
San Diego, CA 92121

p: (858) 752-6170
e: info@cidara.com

ABOUT

PIPELINE

REZAFUNGIN

CLOUDBREAK®

PUBLICATIONS

NEWSROOM

INVESTORS

CAREERS



SUBSCRIBE

© 2022 Cidara Therapeutics, Inc. | Terms of Use | Privacy and Cookies Policy



 * About
   * Overview
   * Leadership
   * Board of Directors
   * Scientific Advisory Board
 * Pipeline
 * Rezafungin
   * Overview
   * Treatment
   * Prevention
   * Expanded Access Policy
 * Cloudbreak®
   * Overview
   * Influenza
   * SARS-CoV-2 and Other Viruses
   * Oncology
 * Investors
   * Investor Overview
   * Press Releases
   * Events + Presentations
   * Company Information
   * Stock Information
   * Analyst Coverage
   * SEC Filings
   * Corporate Governance
   * News Alerts

 * Partnerships
 * Publications
 * Newsroom
 * Careers
 * Contact

 * 
 * 
 * 
 * 



This website uses cookies to simplify and improve your experience of this
website. You can opt-out if you wish. Accept Reject Read More
Privacy & Cookies Policy
Close

PRIVACY OVERVIEW

This website uses cookies to improve your experience while you navigate through
the website. Out of these cookies, the cookies that are categorized as necessary
are stored on your browser as they are essential for the working of basic
functionalities...
Analytics
analytics
This is an non-necessary category.
Non Necessary
non-necessary
This is an non-necessary category.
Save & Accept